| UHC Surest Medical and Drug | Briumvi® (Ublituximab-Xiiy) – Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Bronchial Thermoplasty – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Brow Ptosis and Eyelid Repair – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Cardiovascular Disease Risk Tests – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Carrier Testing Panels for Genetic Diseases – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Chelation Therapy – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Clinical Trials – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Clotting Factors, Coagulant Blood Products, & Other Hemostatics - Commercial Medical Benefit Drug Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Cochlear Implants – Commercial and Individual Exchange Medical Policy | 2026-01-01 |
| UHC Surest Medical and Drug | Cognitive Rehabilitation and Coma Stimulation – Commercial and Individual Exchange Medical Policy | 2026-01-01 |